Cargando…
LILRB3 suppresses immunity in glioma and is associated with poor prognosis
Autores principales: | Zhuang, Qiyuan, Liu, Ying, Wang, Hanze, Lin, Ziyang, Sun, Li, Liu, Yue, Lyu, Yingying, Chen, Liang, Yang, Hui, Mao, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570768/ https://www.ncbi.nlm.nih.gov/pubmed/37830127 http://dx.doi.org/10.1002/ctm2.1396 |
Ejemplares similares
-
Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma
por: Zou, Renheng, et al.
Publicado: (2023) -
LEPRE1 shapes a non‐flamed tumour immune landscape and predicts the prognosis in esophageal squamous cell carcinoma
por: Liu, Meng, et al.
Publicado: (2023) -
Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients
por: Zhang, Yawei, et al.
Publicado: (2021) -
LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy
por: Sharma, Naveen, et al.
Publicado: (2021) -
Molecular regulatory mechanism of LILRB4 in the immune response
por: LIU, Haiyin, et al.
Publicado: (2023)